全文获取类型
收费全文 | 1957篇 |
免费 | 250篇 |
国内免费 | 102篇 |
专业分类
耳鼻咽喉 | 18篇 |
儿科学 | 113篇 |
妇产科学 | 63篇 |
基础医学 | 348篇 |
口腔科学 | 28篇 |
临床医学 | 339篇 |
内科学 | 413篇 |
皮肤病学 | 24篇 |
神经病学 | 77篇 |
特种医学 | 144篇 |
外科学 | 161篇 |
综合类 | 63篇 |
一般理论 | 2篇 |
预防医学 | 209篇 |
眼科学 | 8篇 |
药学 | 156篇 |
中国医学 | 1篇 |
肿瘤学 | 142篇 |
出版年
2022年 | 18篇 |
2021年 | 32篇 |
2020年 | 18篇 |
2019年 | 30篇 |
2018年 | 22篇 |
2017年 | 26篇 |
2016年 | 24篇 |
2015年 | 34篇 |
2014年 | 43篇 |
2013年 | 68篇 |
2012年 | 75篇 |
2011年 | 89篇 |
2010年 | 80篇 |
2009年 | 74篇 |
2008年 | 87篇 |
2007年 | 146篇 |
2006年 | 86篇 |
2005年 | 78篇 |
2004年 | 56篇 |
2003年 | 77篇 |
2002年 | 69篇 |
2001年 | 64篇 |
2000年 | 54篇 |
1999年 | 44篇 |
1998年 | 55篇 |
1997年 | 49篇 |
1996年 | 49篇 |
1995年 | 42篇 |
1994年 | 48篇 |
1993年 | 56篇 |
1992年 | 39篇 |
1991年 | 42篇 |
1990年 | 45篇 |
1989年 | 51篇 |
1988年 | 46篇 |
1987年 | 31篇 |
1986年 | 38篇 |
1985年 | 32篇 |
1984年 | 25篇 |
1983年 | 19篇 |
1982年 | 16篇 |
1981年 | 17篇 |
1980年 | 24篇 |
1979年 | 32篇 |
1978年 | 25篇 |
1977年 | 15篇 |
1976年 | 16篇 |
1975年 | 18篇 |
1973年 | 17篇 |
1972年 | 14篇 |
排序方式: 共有2309条查询结果,搜索用时 31 毫秒
81.
JEFF S. HEALEY M.D. M.Sc. LORNE J. GULA M.D. DAVID H. BIRNIE M.D. LAWRENCE STERNS M.D. STUART J. CONNOLLY M.D. JOHN SAPP M.D. EUGENE CRYSTAL M.D. CHRIS SIMPSON M.D. DEREK V. EXNER M.D. M.P.H. TERESA KUS M.D. FRANCOIS PHILIPPON M.D. GEORGE WELLS Ph.D. ANTHONY SL. TANG M.D. 《Journal of cardiovascular electrophysiology》2012,23(12):1313-1316
Comparing ICD Implantation with and Without Intraoperative Defibrillation Testing. Introduction: The need to perform defibrillation testing (DT) at the time of implantable cardioverter defibrillator (ICD) insertion is controversial. In the absence of randomized trials, some regions now perform more than half of ICD implants without DT. Methods: During the last year of enrolment in the Resynchronization for Ambulatory Heart Failure Trial, a substudy randomized patients to ICD implantation with versus without DT. Results: Among 252 patients screened, 145 were enrolled; 75 randomized to DT and 70 to no DT. Patients were similar in terms of age (65.9 ± 9.3 years vs 67.9 ± 8.9 years); LVEF (24.7 ± 4.6% vs 23.6 ± 4.6%), QRS width (154.8 ± 23.5 vs 155.8 ± 23.6 ms), and history of atrial fibrillation (5% vs 6%). All 68 patients in the DT arm tested according to the protocol achieved a successful DT (≤25 J); 96% without requiring any system modification. No patient experienced perioperative stroke, myocardial infarction, heart failure (HF), intubation or unplanned ICU stay. The length of hospital stay was not prolonged in the DT group: 20.2 ± 26.3 hours versus 21.3 ± 23.0 hours, P = 0.79. One patient in the DT arm had a failed appropriate shock and no patient suffered an arrhythmic death. The composite of HF hospitalization or all‐cause mortality occurred in 10% of patients in the no‐DT arm and 19% of patients in the DT arm (HR = 0.53, 95% CI: 0.21–1.31, P = 0.14). Conclusions: In this randomized trial, perioperative complications, failed appropriate shocks, and arrhythmic death were all uncommon regardless of DT. There was a nonsignificant increase in the risk of death or HF hospitalization with DT. (J Cardiovasc Electrophysiol, Vol. 23, pp. 1313‐1316, December 2012) 相似文献
82.
MA Suckow SL Voytik-Harbin LA Terril SF Badylak 《Journal of investigative surgery》2013,26(5):277-287
Small instestinal submucosa (SIS) is an easily produced material that has been used experimentally for tissue engineering. To evaluate the ability of SIS to facilitate bone growth within a long-bone defect, a segment of the radius was surgically removed in adult, female Sprague-Dawley rats. The defect was either left unfilled or implanted with SIS, demineralized cortical bone (DMCB), or ovalbumin. The defect was evaluated radiographically and histologically after 3, 6, 12, and 24 weeks. Tissue remodeling within the defect was evident by week 3 in SIS- and DMCB-treated rats. Filling was characterized initially by infiltration of mononuclear cells and extracellular material in SIS-implanted rats and multifocal remodeling bone particles and cartilage formation in DMCB implanted rats. Cartilage was observed as early as 3 weeks and bone as early as 6 weeks in SIS-implanted rats. Filling of the defect arose from multiple foci in DMCB-implanted rats, but was contiguous with and parallel to the ulnar shaft in SIS-implanted rats, suggesting that defect repair by SIS may be conductive rather than inductive. Rats in which the defect was left unfilled demonstrated slow but progressive filling of the defect, characterized by mononuclear cell infiltrates and fibrous extracellular material. In summary, SIS facilitated rapid filling of a longbone defect. These results suggest that SIS may be useful as a bone repair material. 相似文献
83.
Akira Kawamura Ilyas Washington Doina M. Mihai Francesca Bartolini Gregg G. Gundersen Milica Tesic Mark Koji Nakanishi 《Chemical biology & drug design》2017,89(4):475-481
Ginkgolides are terpene trilactones in Ginkgo biloba, a popular medicinal herb for memory disorders. Although ginkgolides are known for various neurobiological effects, their macromolecular target in brain is unknown. In this work, we employed benzophenone derivatives of ginkgolides to identify their binding target in brain. Photolabeling of bovine hippocampus homogenates identified a series of α‐tubulin isotypes. Selective photolabeling of α‐tubulin over β‐tubulin, which is equally abundant in brain, suggested that ginkgolides might modulate microtubule biology differently than typical microtubule‐binding agents, such as taxol. In fact, ginkgolide A did not affect microtubule polymerization or cell proliferation; instead, it inhibited detyrosination of α‐tubulin and reorientation of microtubule‐organizing centers. Taken together, the current findings indicate that ginkgolides constitute a new class of microtubule‐binding agents with distinct effects on α‐tubulin biology. 相似文献
84.
85.
A novel chimeric Plasmodium vivax circumsporozoite protein induces biologically functional antibodies that recognize both VK210 and VK247 sporozoites
下载免费PDF全文
![点击此处可从《Infection and immunity》网站下载免费的PDF全文](/ch/ext_images/free.gif)
Yadava A Sattabongkot J Washington MA Ware LA Majam V Zheng H Kumar S Ockenhouse CF 《Infection and immunity》2007,75(3):1177-1185
A successful vaccine against Plasmodium vivax malaria would significantly improve the health and quality of the lives of more than 1 billion people around the world. A subunit vaccine is the only option in the absence of long-term culture of P. vivax parasites. The circumsporozoite protein that covers the surface of Plasmodium sporozoites is one of the best-studied malarial antigens and the most promising vaccine in clinical trials. We report here the development of a novel "immunologically optimal" recombinant vaccine expressed in Escherichia coli that encodes a chimeric CS protein encompassing repeats from the two major alleles, VK210 and VK247. This molecule is widely recognized by sera from patients naturally exposed to P. vivax infection and induces a highly potent immune response in genetically disparate strains of mice. Antibodies from immunized animals recognize both VK210 and VK247 sporozoites. Furthermore, these antibodies appear to be protective in nature since they cause the agglutination of live sporozoites, an in vitro surrogate of sporozoite infectivity. These results strongly suggest that recombinant CS is biologically active and highly immunogenic across major histocompatibility complex strains and raises the prospect that in humans this vaccine may induce protective immune responses. 相似文献
86.
Jacob Matthew Eckstein Nicole Nolan Erin Healy Chadwick Lewis Wright Angita Jain Christian Louis Barney Iman Washington Joseph Paul McElroy John Christopher Grecula Jessica Lynn Wobb Darrion Luther Mitchell Eric Miller Mauricio Gamez Dukagjin Blakaj Virginia Diavolitsis Aashish Bhatt 《Head & neck》2020,42(9):2405-2413
87.
Further characterization of factor VIII-deficient mice created by gene targeting: RNA and protein studies 总被引:6,自引:7,他引:6
Bi L; Sarkar R; Naas T; Lawler AM; Pain J; Shumaker SL; Bedian V; Kazazian HH Jr 《Blood》1996,88(9):3446-3450
88.
When amphipathic cationic drugs are added to intact human RBCs, the RBCs first undergo a stomatocytic shape change and then, if relatively large amounts of drug are added and if the metabolic state of the RBC is appropriate, endocytic vacuoles form. Vanadate has a structural similarity to the transition state of phosphate, which presumably accounts for its ability to inhibit phosphohydrolases, although other actions of vanadate have been described. Vanadate inhibited three forms of drug-induced endocytosis in intact RBCs despite the fact that the three drugs chosen (primaquine, chlorpromazine, and vinblastine) are known to have differing requirements for RBC ATP. Vanadate also inhibited the stomatocytic shape change produced by primaquine, chlorpromazine, and vinblastine, but not the stomatocytosis produced by low pH. Vanadate had no effect on RBC echinocytosis produced by lysophosphatidylcholine. In studying endocytosis in hypotonic, leaky, "white" ghosts, we discovered that vanadate inhibited only the endocytosis produced by Mg-ATP and not the endocytosis produced by manipulations that directly attack the cytoskeletal proteins. These findings suggest that ATP hydrolysis has a role in some forms of amphipathic cation-induced stomatocytosis and endocytosis in intact RBCs. In addition, studies in ghosts support the idea that Mg-ATP does indeed produce "energized" endocytosis dependent on utilization or hydrolysis of ATP. 相似文献
89.
Molecular characterization of a high A2 beta thalassemia by direct sequencing of single strand enriched amplified genomic DNA 总被引:2,自引:0,他引:2
Two families, one of Anglo-Saxon-Dutch descent, and the other, West Indian black, have an atypical beta thalassemia characterized by an unusually high level of Hb A2 in the heterozygous state. Restriction endonuclease mapping showed a deletion of about 1.35 kilobase (kb) in the 5' region of the beta globin gene. Direct sequencing of a specific region of genomic DNA amplified by a new modification of the polymerase chain reaction defined the deletion to be 1,393 base pairs (bp) and to be the same in both families. The deletion extends from 485 bp 5' to the mRNA CAP site to the middle of the second intervening sequence. This deletion, together with three others previously described that remove the 5' end of the beta gene but leave the delta gene intact, are all associated with unusually high levels of Hb A2 in the heterozygous state. 相似文献
90.
Lindsay S. Womack William M. Sappenfield Cheryl L. Clark Washington C. Hill Robert W. Yelverton John S. Curran Linda A. Detman Vani R. Bettegowda 《Maternal and child health journal》2014,18(8):1893-1904
Non-medically indicated (NMI) deliveries prior to 39 weeks increase the risk of neonatal mortality, excess morbidity, and health care costs. The study’s purpose was to identify maternal and hospital characteristics associated with NMI deliveries prior to 39 weeks. The study included 207,775 births to women without a previous cesarean and 38,316 births to women with a previous cesarean, using data from Florida’s 2006–2007 linked birth certificate and inpatient record file. Adjusted risk ratios (ARR) and 95 % confidence intervals (CI) for characteristics were calculated using generalized estimating equation for multinomial logistic regression. Among women without a previous cesarean, NMI deliveries occurred in 18,368 births (8.8 %). Non-medically indicated inductions were more likely in women who were non-Hispanic white (ARR: 1.41, 95 % CI 1.31–1.52), privately-insured (ARR: 1.42, 95 % CI 1.26–1.59), and delivered in hospitals with <500 births per year. Non-medically indicated primary cesareans were more likely in women who were older than 35 years (ARR: 2.96, 95 % CI 2.51–3.50), non-Hispanic white (ARR: 1.44, 95 % CI 1.30–1.59), and privately-insured (ARR: 1.43, 95 % CI 1.17–1.73). Non-medically indicated primary cesareans were also more likely to occur in hospitals with <30 % nurse-midwife births, <500 births per year, and in large metro areas. Among women with previous cesarean, NMI repeat cesareans occurred in 16,746 births (43.7 %). Only weak risk factors were identified for NMI repeat cesareans. The risk factors identified varied by NMI outcome. This information can be used to inform educational campaigns and identify hospitals that may benefit from quality improvement efforts. 相似文献